amiloride, hydrochlorothiazide drug combination has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Motro, M; Shemesh, J | 1 |
| Gariépy, J; Levenson, J; Moyse, D; Simon, A | 1 |
2 trial(s) available for amiloride, hydrochlorothiazide drug combination and Disease Exacerbation
| Article | Year |
|---|---|
Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics.
Topics: Aged; Amiloride; Calcinosis; Calcium Channel Blockers; Cardiomyopathies; Coronary Artery Disease; Disease Progression; Diuretics; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Longitudinal Studies; Male; Middle Aged; Nifedipine; Tomography, X-Ray Computed | 2001 |
Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes.
Topics: Aged; Aged, 80 and over; Amiloride; Antihypertensive Agents; Atenolol; Blood Pressure; Carotid Artery, Common; Carotid Stenosis; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; France; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Risk Factors; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2001 |